Citius Pharmaceuticals, Inc.CTXRNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank13
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-36.68M
↓ 42% vs avg
Percentile
P13
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-25.78M
Historical baseline
PeriodValueYoY Change
TTM$-36.68M+4.0%
2025$-38.20M+1.1%
2024$-38.64M-21.6%
2023$-31.77M+3.4%
2022$-32.88M-43.7%
2021$-22.88M-31.6%
2020$-17.38M-11.8%
2019$-15.54M-12.7%
2018$-13.79M-38.1%
2017$-9.98M-